Uncategorized

Image of Alex

Alexandre Nossovskoi

By Sixty Degree Capital | January 11, 2023

Alexandre is a Principal at Sixty Degree Capital, where he focuses on technology investment in digital infrastructure and transformative software innovation. Prior to joining SDC, he gained valuable experience in the venture capital and innovation space through his work at…

Read More
Brett Liu

Brett Liu MEng

By pwsbuilder | January 11, 2023

Brett joined Sixty Degree Capital in May 2021 as a Principal. Prior to joining, Brett worked 7 years in investment in the energy and related technology sector, and completed several acquisitions and private equity investments with a total deal value…

Read More
Robin Gao

Robin Gao MMI

By pwsbuilder | January 11, 2023

Robin joined Sixty Degree Capital in November 2019. Prior to joining, Robin worked for Toronto healthcare startups AmacaThera and Focal Healthcare in both business development and fundraising roles. Previously, Robin worked for ApoPharma’s pre-clinical research division as well as also…

Read More

Antios Therapeutics Raises $96 Million in a Series B Financing

By Sixty Degree Capital | October 21, 2021

Funding will support the Phase 2 clinical program of ATI-2173 in HBV Soleus Capital led the round with new major investors RA Capital Management, Adage Capital Management LP, Pontifax and Aisling Capital as well as Altium Capital, Amzak Health, Granite…

Read More

Arcellx Closes $115 Million Series C Financing to Advance its Pipeline of Adaptive and Controllable Cell Therapies

By Sixty Degree Capital | October 20, 2021

GAITHERSBURG, Md., April 13, 2021 (GLOBE NEWSWIRE) – – Arcellx, a privately held clinical-stage biopharmaceutical company, today announced that it raised $115 million in a Series C financing to advance its pipeline of adaptive and controllable cell therapies. The proceeds…

Read More

Arcellx Announces Executive Appointments

By Sixty Degree Capital | October 20, 2021

Dr. Christopher Heery joins as Chief Medical Officer and Neeraj Teotia joins as Chief Commercial Officer GAITHERSBURG, Md., April 19, 2021 (GLOBE NEWSWIRE) – – Arcellx, a privately held clinical-stage biopharmaceutical company, today announced that it has hired two new…

Read More